CTI BIOPHARMA CORP (CTIC)
US12648L6011 - Common Stock
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer.
Sobi completes acquisition of CTI BioPharma Corp.
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the completion of the...
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) announced today that it has, through its indirect wholly owned subsidiary Cleopatra...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, NATI, CTIC, USX
/PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, FRG, MMP
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Moore Kuehn Encourages HMPT, ABST, CTIC and FRG Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, MNTV, CTIC, HMPT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Notable Wednesday Option Activity: CTIC, HD, MARA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Why Shares of CTI BioPharma Are Soaring Wednesday
A buyout offer from Swedish Orphan Biovitrum drove up the stock's price.
Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi
/PRNewswire/ -- Ademi LLP is investigating CTI BioPharma (Nasdaq: CTIC) for possible breaches of fiduciary duty and other violations of law in its transaction...
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors.
Why Is SeaStar Medical (ICU) Stock Down 32% Today?
SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA.
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
Why Is Babylon (BBLN) Stock Down 57% Today?
Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private.
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday!
Swedish Orphan Biovitrum Ab to acquire CTI BioPharma for $9.10 per share (NASDAQ:CTIC)
Swedish Orphan Biovitrum AB or SOBI, a global healthcare leader in hematology, immunology and specialty care, will acquire CTI BioPharma (CTIC) for $9.10 per share in an...
Sobi to Acquire CTI BioPharma
/PRNewswire/ -- CTI BioPharma (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...